I’m not sure if this applies to the cannabis industry. For pharma companies readying to place a generic on the market, they’ll usually formulate their product by reverse-engineering the brand months before the patent expires and then run to the FDA office the day before and even camp overnight to be the first ones in for the permit. Then the patent expires the next morning, they get all their paperwork straight, and magically have stock for the shelves instantly. Maybe something like that happens in other industries. Either way, it’s interesting how business is done in these gray areas.
I’m not sure if this applies to the cannabis industry. For pharma companies readying to place a generic on the market, they’ll usually formulate their product by reverse-engineering the brand months before the patent expires and then run to the FDA office the day before and even camp overnight to be the first ones in for the permit. Then the patent expires the next morning, they get all their paperwork straight, and magically have stock for the shelves instantly. Maybe something like that happens in other industries. Either way, it’s interesting how business is done in these gray areas.